Mirum Pharmaceuticals: VISTAS - A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by PSC

2022 Kowdley, K et al. Impact of pruritus in primary sclerosing cholangitis (PSC): a multinational survey. Journal of Hepatology, Vol 77 EASL ILC Abstracts. Please find Abstract # THU442 (on page 337 via online pagination; p. S312 of journal; or use cntrl-f THU442 to search the document for the abstract). Text available without subscription at 10.1016/S0168-8278(22)00991-6 Notes: A multinational survey (39 questions) of PSC patients (n=482) focused on the impact of itch, how itch severity affected quality of life (QoL), and therapeutic interventions used to address itch. Responses collected June 2020 - Feb 2021.